Divergent Hemogen Genes of Teleosts and Mammals Share Conserved Roles in Erythropoiesis: Analysis Using Transgenic and Mutant Zebrafish Michael J

Total Page:16

File Type:pdf, Size:1020Kb

Divergent Hemogen Genes of Teleosts and Mammals Share Conserved Roles in Erythropoiesis: Analysis Using Transgenic and Mutant Zebrafish Michael J © 2018. Published by The Company of Biologists Ltd | Biology Open (2018) 7, bio035576. doi:10.1242/bio.035576 RESEARCH ARTICLE Divergent Hemogen genes of teleosts and mammals share conserved roles in erythropoiesis: analysis using transgenic and mutant zebrafish Michael J. Peters, Sandra K. Parker, Jeffrey Grim*, Corey A. H. Allard‡, Jonah Levin§ and H. William Detrich, III¶ ABSTRACT (Krüger et al., 2002, 2005). Here we analyze the developmental Hemogen is a vertebrate transcription factor that performs important roles of teleost Hemogen using the zebrafish model system and its functions in erythropoiesis and testicular development and may powerful suite of reverse-genetic technologies. contribute to neoplasia. Here we identify zebrafish Hemogen and Teleost Hemogen was discovered using a subtractive show that it is considerably smaller (∼22 kDa) than its human ortholog hybridization screen designed to isolate novel erythropoietic (∼55 kDa), a striking difference that is explained by an underlying genes from fish belonging to the largely Antarctic suborder modular structure. We demonstrate that Hemogens are largely Notothenioidei (Detrich and Yergeau, 2004; Yergeau et al., composed of 21-25 amino acid repeats, some of which may function 2005). Sixteen species belonging to the icefish family as transactivation domains (TADs). Hemogen expression in embryonic (Channichthyidae) are unique among vertebrates because they are and adult zebrafish is detected in hematopoietic, renal, neural and white-blooded; they fail to execute the erythroid genetic program or gonadal tissues. Using Tol2- and CRISPR/Cas9-generated transgenic produce hemoglobin (Cocca et al., 1995; Near et al., 2006; Zhao zebrafish, we show that Hemogen expression is controlled by two et al., 1998). Forty-five candidate erythropoietic cDNAs were Gata1-dependent regulatory sequences that act alone and together to recovered using representational difference analysis (Hubank and control spatial and temporal expression during development. Partial Schatz, 1999) applied to kidney marrow transcriptomes of two depletion of Hemogen in embryos by morpholino knockdown reduces notothenioid species, one red-blooded and the other white-blooded the number of erythrocytes in circulation. CRISPR/Cas9-generated (Detrich and Yergeau, 2004; Yergeau et al., 2005). One of the zebrafish lines containing either a frameshift mutation or an in-frame unknown genes, clone Rda130, was similar to mammalian deletion in a putative, C-terminal TAD display anemia and embryonic Hemogen and was expressed only by the red-blooded notothenioid. tail defects. This work expands our understanding of Hemogen and Although Hemogen is clearly involved in hematopoiesis, its provides mutant zebrafish lines for future study of the mechanism of mechanism remains incompletely understood. In human cell lines, this important transcription factor. Hemogen activates erythroid gene transcription in part by recruiting the histone acetyltransferase P300 to acetylate Gata1 (Zheng et al., KEY WORDS: Anemia, CRISPR/Cas9, Gene editing, Hematopoiesis, 2014). Like Gata1, Hemogen protects erythroid cells from apoptosis Transcription by upregulating anti-apoptotic factors (e.g. Nf-κB, Bcl-xL) that are critical for terminal differentiation (Li et al., 2004; Rhodes et al., INTRODUCTION 2005; Zhang et al., 2012). Hemogen (Hemgn) is a vertebrate transcription factor that is The regulation of Hemogen expression is of interest because it is expressed in mammalian hematopoietic progenitors (Lu et al., 2001; overexpressed frequently in patients with a variety of cancers and Yang et al., 2001) and has been implicated in erythroid leukemias (An et al., 2005; Forbes et al., 2017; Li et al., 2004). This differentiation and survival (Li et al., 2004). Originally identified putative oncogene, which is located in a human chromosomal in mice and subsequently described in humans as EDAG region (9q22) of leukemia-associated breakpoints, has been linked (Erythrocyte Differentiation Associated Gene), Hemogen has also to proliferation and survival of leukemic cells and to induction of been implicated in testis development in mammals and chickens tumor formation in mice (Chen et al., 2016; Lu et al., 2002). Thus, (Nakata et al., 2013; Yang et al., 2003), and in osteogenesis in rats somatic mutations in Hemogen or its regulators may contribute to neoplasia. The zebrafish is a well-established model organism for studying Department of Marine and Environmental Sciences, Northeastern University, Nahant, MA 01908, USA. hematopoiesis in vertebrates because it produces the same blood *Present address: Department of Biology, The University of Tampa, Tampa, FL lineages as mammals (de Jong and Zon, 2005; Paffett-Lugassy and ‡ 33606, USA. Present address: Department of Biochemistry and Cell Biology, Zon, 2005). In zebrafish, erythropoiesis occurs in sequential waves at Geisel School of Medicine at Dartmouth College, Hanover, NH 03755, USA. §Present address: Department of Biochemistry, McGill University, Montreal, unique anatomical locations in embryos and adults that correspond to Quebec H3G1Y6, Canada. analogous sites in mammals (Galloway and Zon, 2003). Many of the ¶Author for correspondence ([email protected]) molecular players that orchestrate the erythroid program appear to be conserved between zebrafish and mammals, but relatively few have M.J.P., 0000-0003-4932-528X; J.G., 0000-0002-3344-0657; C.A.H.A., 0000- been functionally characterized in zebrafish. Nevertheless, mutant 0002-3554-2059; H.W.D., 0000-0002-0783-4505 zebrafish models accurately phenocopy human blood diseases caused This is an Open Access article distributed under the terms of the Creative Commons Attribution by mutations in major erythroid factors, such as Gata1 (Lyons et al., License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. 2002) and Erythroid beta-spectrin (Liao et al., 2000). The purpose of this study is to characterize the regulation of Received 7 May 2018; Accepted 16 July 2018 Hemogen expression and the function of the Hemogen protein in Biology Open 1 RESEARCH ARTICLE Biology Open (2018) 7, bio035576. doi:10.1242/bio.035576 Fig. 1. Zebrafish Si:dkey-25o16.2 and human Hemogen are orthologous and encode related proteins that differ in size. (A) Structure of the zebrafish Hemogen-like gene, Si:dkey-25o16.2. Two conserved noncoding elements (C1 and C2, black boxes) were identified in a 2 kb segment proximal to the start codon (see Results, Figs 4-6). Coding exons, white boxes; noncoding exons, gray boxes. Numbers indicate length in bp. (B) Synteny of loci for zebrafish Si:dkey-25o16.2 on chromosome 1 and Hemogen on human chromosome 9 (region q22). Transcriptional orientations indicated by arrows. (C) Alternative splicing of zebrafish Hemogen-like transcripts showing sequenced regions. Introns are shown as chevrons. Transcripts 1 and 2 differ by retention of 12 bp of intron (red). (D) Modular structures of zebrafish and human Hemogen proteins each encoded by four exons (numbered boxes). Locations of truncating mutations found in some human cancers (Forbes et al., 2017) are indicated by asterisks. Predicted regions and motifs: green, coiled coil; blue, nuclear localization signal; red, four residues introduced by alternative splicing; yellow, tandem peptide repeats; brown, acidic repeat with transactivation domain (TAD) motif; gray, no prediction. (E) Three-dimensional ab initio models of Hemogens. The ribbon diagram of the zebrafish protein, color-coded as in panel D, is superimposed on the gray, space-filling model for the human protein (See Materials and Methods). zebrafish. We identify the zebrafish Hemogen ortholog, which predicted gene Si:dkey-25o16.2 on chromosome 1 of the zebrafish despite being only 40% as large as the human protein, contains genome (Howe et al., 2013). When we compared the synteny of the similarly arranged functional motifs. Hemogen is expressed in putative teleost and mammalian orthologs, represented in Fig. 1B blood, testis, ovaries, kidneys and the central nervous system in by zebrafish Si:dkey-25o16.2 (chromosome Dr1) and human zebrafish. Two tissue-specific, alternative Hemogen promoters Hemogen (chromosome Hs9), we found that the flanking genes are associated with conserved noncoding elements (CNEs) and and their transcriptional orientations were conserved, which have distinct regulatory functions in primitive and definitive strongly supported Si:dkey-25o16.2 as the zebrafish Hemogen hematopoiesis and other processes. By analysis of morphant and ortholog. mutant zebrafish, we show that Hemogen is required for normal erythropoiesis and that this role depends in part on a cluster of acidic Structure of the zebrafish Hemogen gene residues within a putative, C-terminal transactivation domain The basic structure of the Hemogen gene of teleosts and mammals (TAD). was also found to be highly conserved; four coding exons were separated by three introns (Fig. 1A), and two introns were found in RESULTS the 5′-UTR. Two transcription start sites were predicted to occur Teleosts contain a single Hemogen-like gene that is syntenic within 2 kb upstream of the Hemogen start codon in zebrafish with human Hemogen (Fig. 1A) and these appear to correspond to the hematopoietic- and Chromosomal synteny is an important criterion when assigning testis-specific Hemogen promoters (noncoding exons 1H and 1T, gene relationships across divergent
Recommended publications
  • Investigation of Key Genes and Pathways in Inhibition of Oxycodone on Vincristine-Induced Microglia Activation by Using Bioinformatics Analysis
    Hindawi Disease Markers Volume 2019, Article ID 3521746, 10 pages https://doi.org/10.1155/2019/3521746 Research Article Investigation of Key Genes and Pathways in Inhibition of Oxycodone on Vincristine-Induced Microglia Activation by Using Bioinformatics Analysis Wei Liu,1 Jishi Ye,2 and Hong Yan 1 1Department of Anesthesiology, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, China 2Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, 430060 Hubei, China Correspondence should be addressed to Hong Yan; [email protected] Received 2 November 2018; Accepted 31 December 2018; Published 10 February 2019 Academic Editor: Hubertus Himmerich Copyright © 2019 Wei Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Introduction. The neurobiological mechanisms underlying the chemotherapy-induced neuropathic pain are only partially understood. Among them, microglia activation was identified as the key component of neuropathic pain. The aim of this study was to identify differentially expressed genes (DEGs) and pathways associated with vincristine-induced neuropathic pain by using bioinformatics analysis and observe the effects of oxycodone on these DEG expressions in a vincristine-induced microglia activation model. Methods. Based on microarray profile GSE53897, we identified DEGs between vincristine-induced neuropathic pain rats and the control group. Using the ToppGene database, the prioritization DEGs were screened and performed by gene ontology (GO) and signaling pathway enrichment. A protein-protein interaction (PPI) network was used to explore the relationship among DEGs.
    [Show full text]
  • A Draft Map of the Human Proteome
    ARTICLE doi:10.1038/nature13302 A draft map of the human proteome Min-Sik Kim1,2, Sneha M. Pinto3, Derese Getnet1,4, Raja Sekhar Nirujogi3, Srikanth S. Manda3, Raghothama Chaerkady1,2, Anil K. Madugundu3, Dhanashree S. Kelkar3, Ruth Isserlin5, Shobhit Jain5, Joji K. Thomas3, Babylakshmi Muthusamy3, Pamela Leal-Rojas1,6, Praveen Kumar3, Nandini A. Sahasrabuddhe3, Lavanya Balakrishnan3, Jayshree Advani3, Bijesh George3, Santosh Renuse3, Lakshmi Dhevi N. Selvan3, Arun H. Patil3, Vishalakshi Nanjappa3, Aneesha Radhakrishnan3, Samarjeet Prasad1, Tejaswini Subbannayya3, Rajesh Raju3, Manish Kumar3, Sreelakshmi K. Sreenivasamurthy3, Arivusudar Marimuthu3, Gajanan J. Sathe3, Sandip Chavan3, Keshava K. Datta3, Yashwanth Subbannayya3, Apeksha Sahu3, Soujanya D. Yelamanchi3, Savita Jayaram3, Pavithra Rajagopalan3, Jyoti Sharma3, Krishna R. Murthy3, Nazia Syed3, Renu Goel3, Aafaque A. Khan3, Sartaj Ahmad3, Gourav Dey3, Keshav Mudgal7, Aditi Chatterjee3, Tai-Chung Huang1, Jun Zhong1, Xinyan Wu1,2, Patrick G. Shaw1, Donald Freed1, Muhammad S. Zahari2, Kanchan K. Mukherjee8, Subramanian Shankar9, Anita Mahadevan10,11, Henry Lam12, Christopher J. Mitchell1, Susarla Krishna Shankar10,11, Parthasarathy Satishchandra13, John T. Schroeder14, Ravi Sirdeshmukh3, Anirban Maitra15,16, Steven D. Leach1,17, Charles G. Drake16,18, Marc K. Halushka15, T. S. Keshava Prasad3, Ralph H. Hruban15,16, Candace L. Kerr19{, Gary D. Bader5, Christine A. Iacobuzio-Donahue15,16,17, Harsha Gowda3 & Akhilesh Pandey1,2,3,4,15,16,20 The availability of human genome sequence has transformed biomedical research over the past decade. However, an equiv- alent map for the human proteome with direct measurements of proteins and peptides does not exist yet. Here we present a draft map of the human proteome using high-resolution Fourier-transform mass spectrometry.
    [Show full text]
  • Atypical Chromosome Abnormalities in Acute Myeloid Leukemia Type M4
    Genetics and Molecular Biology, 30, 1, 6-9 (2007) Copyright by the Brazilian Society of Genetics. Printed in Brazil www.sbg.org.br Short Communication Atypical chromosome abnormalities in acute myeloid leukemia type M4 Agnes C. Fett-Conte1, Roseli Viscardi Estrela2, Cristina B. Vendrame-Goloni3, Andréa B. Carvalho-Salles1, Octávio Ricci-Júnior4 and Marileila Varella-Garcia5 1Departamento de Biologia Molecular, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, SP, Brazil. 2Austa Hospital, São José do Rio Preto, SP, Brazil. 3Departamento de Biologia, Instituto de Biociências, Letras e Ciências Exatas, Universidade Estadual Paulista, São José do Rio Preto, SP, Brazil. 4Hemocentro, São José do Rio Preto, SP, Brazil. 5Comprehensive Cancer Center, University of Colorado, Denver, CO, USA. Abstract This study reports an adult AML-M4 patient with atypical chromosomal aberrations present in all dividing bone mar- row cell at diagnosis: t(1;8)(p32.1;q24.2), der(9)t(9;10)(q22;?), and ins(19;9)(p13.3;q22q34) that may have origi- nated transcripts with leukemogenic potential. Key words: acute myeloid leukemia, chromosomal abnormalities, chromosomal translocations. Received: February 10, 2006; Accepted: June 22, 2006. Acute non-lymphocytic or myelogenous leukemia (Mitelman Database of Chromosome Aberration in Cancer (ANLL or AML) represents a hematopoietic malignancy 2006). Karyotype is generally an important prognostic fac- characterized by abnormal cell proliferation and stalled dif- tor in AML, a favorable prognosis being associated with ferentiation leading to the accumulation of immature cells minor karyotypic changes, low frequency of abnormal in the marrow itself, in peripheral blood and eventually in bone marrow cells and changes specifically involving the other tissues.
    [Show full text]
  • Expression Profiling of Sexually Dimorphic Genes in the Japanese
    www.nature.com/scientificreports OPEN Expression profling of sexually dimorphic genes in the Japanese quail, Coturnix japonica Miki Okuno1,5, Shuntaro Miyamoto2,5, Takehiko Itoh1, Masahide Seki3, Yutaka Suzuki3, Shusei Mizushima2,4 & Asato Kuroiwa2,4* Research on avian sex determination has focused on the chicken. In this study, we established the utility of another widely used animal model, the Japanese quail (Coturnix japonica), for clarifying the molecular mechanisms underlying gonadal sex diferentiation. In particular, we performed comprehensive gene expression profling of embryonic gonads at three stages (HH27, HH31 and HH38) by mRNA-seq. We classifed the expression patterns of 4,815 genes into nine clusters according to the extent of change between stages. Cluster 2 (characterized by an initial increase and steady levels thereafter), including 495 and 310 genes expressed in males and females, respectively, contained fve key genes involved in gonadal sex diferentiation. A GO analysis showed that genes in this cluster are related to developmental processes including reproductive structure development and developmental processes involved in reproduction were signifcant, suggesting that expression profling is an efective approach to identify novel candidate genes. Based on RNA-seq data and in situ hybridization, the expression patterns and localization of most key genes for gonadal sex diferentiation corresponded well to those of the chicken. Our results support the efectiveness of the Japanese quail as a model for studies gonadal sex diferentiation in birds. In birds, males are homogametic (ZZ) and females are heterogametic (ZW). Te sex determination mechanism involving gene(s) on the sex chromosome is highly conserved among birds. In chickens, sex determination is thought to occur afer embryonic day (E) 4.5, corresponding to Hamburger and Hamilton stage1 24 (HH24).
    [Show full text]
  • Gene Duplication and Neofunctionalization: POLR3G and POLR3GL
    Downloaded from genome.cshlp.org on September 27, 2021 - Published by Cold Spring Harbor Laboratory Press Research Gene duplication and neofunctionalization: POLR3G and POLR3GL Marianne Renaud,1 Viviane Praz,1,2 Erwann Vieu,1,5 Laurence Florens,3 Michael P. Washburn,3,4 Philippe l’Hoˆte,1 and Nouria Hernandez1,6 1Center for Integrative Genomics, Faculty of Biology and Medicine, University of Lausanne, 1015 Lausanne, Switzerland; 2Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland; 3Stowers Institute for Medical Research, Kansas City, Missouri 64110, USA; 4Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, Kansas 66160, USA RNA polymerase III (Pol III) occurs in two versions, one containing the POLR3G subunit and the other the closely related POLR3GL subunit. It is not clear whether these two Pol III forms have the same function, in particular whether they recognize the same target genes. We show that the POLR3G and POLR3GL genes arose from a DNA-based gene duplication, probably in a common ancestor of vertebrates. POLR3G- as well as POLR3GL-containing Pol III are present in cultured cell lines and in normal mouse liver, although the relative amounts of the two forms vary, with the POLR3G-containing Pol III relatively more abundant in dividing cells. Genome-wide chromatin immunoprecipitations followed by high-throughput sequencing (ChIP-seq) reveal that both forms of Pol III occupy the same target genes, in very constant proportions within one cell line, suggesting that the two forms of Pol III have a similar function with regard to specificity for target genes. In contrast, the POLR3G promoter—not the POLR3GL promoter—binds the transcription factor MYC, as do all other pro- moters of genes encoding Pol III subunits.
    [Show full text]
  • Iron Deficiency Modifies Gene Expression Variation Induced by Augmented Hypoxia Sensing
    HHS Public Access Author manuscript Author Manuscript Author ManuscriptBlood Cells Author Manuscript Mol Dis. Author Author Manuscript manuscript; available in PMC 2015 January 01. Published in final edited form as: Blood Cells Mol Dis. 2014 January ; 52(1): 35–45. doi:10.1016/j.bcmd.2013.07.016. Iron deficiency modifies gene expression variation induced by augmented hypoxia sensing Xu Zhang1, Wei Zhang2,3, Shwu-Fan Ma4, Galina Miasniakova5, Adelina Sergueeva6, Tatiana Ammosova7, Min Xu7, Sergei Nekhai7, Mehdi Nourai7, Michael S. Wade8,9, Josef T. Prchal10, Joe G. N. Garcia#8,9, Roberto F. Machado#8,9, and Victor R. Gordeuk#1 1Comprehensive Sickle Cell Center, Section of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA 2Department of Pediatrics, University of Illinois at Chicago, Chicago, IL, USA 3Institute of Human Genetics, University of Illinois at Chicago, Chicago, IL, USA 4Section of Pulmonary/Critical Care, Department of Medicine, University of Chicago, Chicago, IL, USA 5Chuvash Republic Clinical Hospital 2, Cheboksary, Russian Federation, Howard University, Washington, DC 6Cheboksary Children's Hospital, Cheboksary, Russian Federation, Howard University, Washington, DC 7Center for Sickle Cell Disease, Howard University, Washington, DC 8Section of Pulmonary, Critical Care & Sleep Medicine, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA 9Institute for Personalized Respiratory Medicine, University of Illinois at Chicago, Chicago, IL, USA 10Departments of Medicine, Pathology and Genetics, University of Utah and VAH © 2013 Elsevier Inc. All rights reserved. Correspondence: Victor R. Gordeuk, MD, Suite 172, Clinical Sciences Building, 820 South Wood St., Chicago, IL 60612-7236 Tel 312-996-5680, Fax 312-996-5984, [email protected].
    [Show full text]
  • Winners Sorted by Institute-Center
    FARE2020WINNERS Sorted By Institute Ji Chen Postdoctoral Fellow CC Neuroscience - General Toward a Wearable Pediatric Robotic Knee Exoskeleton for Real World Overground Gait Rehabilitation in Ambulatory Individuals Crouch gait, or excessive knee flexion, is a debilitating gait pathology in children with cerebral palsy (CP). Surgery, bracing and therapy provide only short term correction of crouch and more sustainable solutions remain a significant challenge in children with CP. One major hurdle is achieving the required dosage and intensity of gait training necessary to produce meaningful long term improvements in walking ability. Rather than replace lost or absent function, gait training in CP population aims to improve the participant’s baseline walking pattern by encouraging longer bouts of training and exercise, which is different than in those with paralysis. Wearable robotic exoskeletons, as a potential strategy, can assist individuals with CP to gradually regain knee extension over time and help maintain it for longer periods through intense task-specific gait training. We previously tested our initial prototype which produced significant improvement in knee extension comparable in magnitude to reported results from orthopedic surgery. Children continued to exert voluntary knee extensor muscle when walking with the exoskeleton which indicated the device was assisting but not controlling their gait. These positive initial results motivated us to design second prototype to expand the user population, and to enable its effective use outside of the laboratory environment. The current version has individualized control capability and device portability for home use as it implemented a multi-layered closed loop control system and a microcontroller based data acquisition system.
    [Show full text]
  • Supplemental Material.Pdf
    Akagi and Li et al SUPPLEMENTAL INFORMATION Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability Keiko Akagi, Jingfeng Li, Tatevik Broutian, Hesed Padilla-Nash, Weihong Xiao, Bo Jiang, James W. Rocco, Theodoros N. Teknos, Bhavna Kumar, Danny Wangsa, Dandan He, Thomas Ried, David E. Symer, Maura L. Gillison SUPPLEMENTAL METHODS PAGE NO. 3 SUPPLEMENTAL FIGURES Supplemental Fig. 1. Broad distribution of breakpoints and rearrangements mapped to the HPV genome in various cancer samples. 5 Supplemental Fig. 2. HPV E6 and E7 oncogene transcripts are expressed in diverse cancers. 7 Supplemental Fig. 3. Comparison of mutational spectra in HPV-positive vs. HPV-negative cancer samples. 8 Supplemental Fig. 4. Genomic copy number changes occur recurrently in diverse cancer samples. 9 Supplemental Fig. 5. Structural variation in various cancer samples. 10 Supplemental Fig. 6. FISH and SKY confirm HPV clusters. 12 Supplemental Fig. 7. Enrichment of hyper-amplification and structural variants around HPV integration sites. 13 Supplemental Fig. 8. Quantitative PCR confirms HPV-associated genomic amplifications. 14 Supplemental Fig. 9. Connectivity maps of additional HPV-associated genomic structural variants in HNSCC cell lines. 16 Supplemental Fig. 10. Gene amplification from HPV-mediated structural variation results in upregulation of FOXE1, C9ORF156 and PIM1 transcripts in UPCI:SCC090 cells. 17 Supplemental Fig. 11. Gene breakage at SLC47A2 in UM-SCC-104 cells. 19 1 Akagi and Li et al SUPPLEMENTAL TABLES Supplemental Table 1. Summary of WGS statistics for 12 cancer samples 20 Supplemental Table 2. Clonal single nucleotide polymorphisms found in HPV16 viral genomes in cancer samples 21 Supplemental Table 3.
    [Show full text]
  • A Pathogenic and Clonally Expanded B Cell Transcriptome in Active Multiple Sclerosis
    A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis Akshaya Ramesha,b,1, Ryan D. Schuberta,b,1, Ariele L. Greenfielda,b,2, Ravi Dandekara,b,2, Rita Loudermilka,b, Joseph J. Sabatino Jra,b, Matthew T. Koelzerc, Edwina B. Trana,b, Kanishka Koshala,b, Kicheol Kima,b, Anne-Katrin Pröbstela,b, Debarko Banerjia,b, University of California, San Francisco MS-EPIC Team3, Chu-Yueh Guoa,b, Ari J. Greena,b, Riley M. Bovea,b, Joseph L. DeRisid,e, Jeffrey M. Gelfanda,b, Bruce A. C. Creea,b, Scott S. Zamvila,b,f, Sergio E. Baranzinia,b, Stephen L. Hausera,b, and Michael R. Wilsona,b,4 aWeill Institute for Neurosciences, University of California, San Francisco, CA 94158; bDepartment of Neurology, University of California, San Francisco, CA 94158; cDepartment of Mathematics, University of California, Los Angeles, CA 90095; dChan Zuckerberg Biohub, San Francisco, CA 94158; eDepartment of Biochemistry and Biophysics, University of California, San Francisco, CA 94158; and fProgram in Immunology, University of California, San Francisco, CA 94143 Edited by Lawrence Steinman, Stanford University School of Medicine, Stanford, CA, and approved August 3, 2020 (received for review May 6, 2020) Central nervous system B cells have several potential roles in may not only shed light on disease pathogenesis but also po- multiple sclerosis (MS): secretors of proinflammatory cytokines tentially provide more disease-specific and safer therapeutic and chemokines, presenters of autoantigens to T cells, producers targets to guide development of the next-generation of B cell of pathogenic antibodies, and reservoirs for viruses that trigger therapeutics. demyelination.
    [Show full text]
  • PDF Hosted at the Radboud Repository of the Radboud University Nijmegen
    PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/100868 Please be advised that this information was generated on 2017-12-06 and may be subject to change. Deciphering cellular responses to pathogens using genomics data Iziah Edwin Sama Deciphering cellular responses to pathogens using genomics data This research was performed at the Centre for Molecular and Biomolecular Informatics (CMBI), Nijmegen Centre of Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Funding: This work was supported by the VIRGO consortium, an Innovative Cluster approved by the Netherlands Genomics Initiative and partially funded by the Dutch Government (BSIK 03012), The Netherlands. ISBN 978-90-9027062-3 © 2012 Iziah Edwin Sama All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, by print or otherwise, without permission in writing from the author Front Cover Image: A metaphorical illustration of the complexity in a host cell (the field), wherein fundamental moieties like proteins interact with each other (the network) in response to various pathogenic stimuli triggering respective cellular responses (the sub-fields demarcated by different line colors). The background is a picture of an indoors multi-sports field .The network is a protein-protein interaction network (HsapiensPPI of chapter 3) in which nodes represent proteins and edges between nodes indicate physical association. (Concept by Iziah Edwin Sama) Cover design and lay-out: In Zicht Grafisch Ontwerp, Arnhem Printed by: Ipskamp Drukkers, Enschede II Deciphering cellular responses to pathogens using genomics data Proefschrift ter verkrijging van de graad van doctor aan de Radboud Universiteit Nijmegen op gezag van de rector magnificus prof.
    [Show full text]
  • Proteomic Characterization of Hemogen in Erythropoiesis
    Proteomic Characterization of Hemogen in Erythropoiesis Brinda Somasundaram This thesis is submitted to the Faculty of Graduate and Postdoctoral Studies in partial fulfillment of the requirements for a Master of Science degree in Cellular and Molecular Medicine. Department of Cellular and Molecular Medicine Faculty of Medicine University of Ottawa August 2nd, 2012 © Brinda Somasundaram, Ottawa, Canada 2012 ABSTRACT Hemogen (Hemgn) is reported as a tissue specific transcriptional regulator in testis as well as hematopoietic tissues. It is known that Hemgn positively regulates erythroid differentiation; however, the underlying molecular mechanism is not well understood. In the current study, using proteomic approach in combination with other molecular biology tools, we have attempted to decipher the role of Hemgn in differentiating Murine erythroblast leukemia (MEL) cells as a model system. Our study reveals that Hemgn predominantly interacts with transcriptional regulators, chromatin modifiers and histones. Furthermore, using Chromatin Immunoprecipitation and knockdown approach, we have demonstrated that Hemgn is recruited to the -globin locus, which is known to be activated during erythroid differentiation. Based on the results, we speculate that Hemgn acts as a tissue specific histone chaperone that regulates transcription during erythroid differentiation. TABLE OF CONTENTS List of Tables………………………………………………………………………. i List of Figures……………………………………………………………………… ii List of Abbreviations………………………………………………………………. iii Dedications and Acknowledgements.……………………………………………... v 1. INTRODUCTION…………………………………………………………….. 1 1.1. Chromatin Structure………………………………………………………... 2 1.2. Hematopoietic system – a brief overview………………………………….. 4 1.3. Erythropoiesis – from HSCs to being erythrocytes………………………... 6 1.4. Transcriptional regulation of erythropoiesis………………………………. 7 1.4.1. Hemogen – a novel transcription regulator………………………………... 8 1.4.2. GATA1 – master regulatory factor of erythropoiesis……………………... 9 1.4.3.
    [Show full text]
  • Table 2S List of the Probe Sets (Each of Them Corresponding to a Gene Or A
    Table 2s List of the probe sets (each of them corresponding to a gene or a gene family) resulting significantly modulated (see Table 1s) in DPTs following 3 hour Dex and whose increased/decreased modulation was above a chosen cut-off (for log increase > 0.75 and for log decrease < -0.5). In the Affymetrix platform each probe set is represented by an ID number (column 1) linked to a gene or gene family (columns 2 and 3). The modulation of the expression in the treated DPTs is reported as log in 2 basis (a 2 fold increase expression is reported as 1 and a 2 fold decrease expression is reported as –1). To allow comparison, the ID numbers of several data banks corresponding to the probe set ID are reported in columns 6- 14 and 19. Gene Ontology numbers and the pathway(s) in which the gene is involved are reported in columns 15-18. Affymetrix GeneChip Array Murine Genome U74Av2 Array Genome March 2005 (NCBI 34) Version column 1 column 2 column 3 column 4 column 5 column 6 column 7 column 8 column 9 column 10 column 11 column 12 column 13 column 14 Transcript Log2 Fold Representative Entrez RefSeq Transcript Probe Set ID Gene Title Gene Symbol ID (Array UniGene ID Ensembl SwissProt EC RefSeq Protein ID MGI Name Modulation Public ID Gene ID Design) ENSMUSG0 Q9CXH2 /// 95151_at RIKEN cDNA 2810052M02 gene 2810052M02Rik -2.8 5674136 AW061307 Mm.29475 67220 --- NP_075809.1 NM_023320 --- 0000015745 Q9JIY0 ENSMUSG0 P41133 /// 92614_at inhibitor of DNA binding 3 Id3 -2 5663577 M60523 Mm.110 15903 --- NP_032347.1 NM_008321 --- 0000007872 Q545W1 5690864_R
    [Show full text]